# Effectiveness of Ivermectin and Doxycycline on COVID-19 Patients

> **NCT04591600** · PHASE1,PHASE2 · COMPLETED · sponsor: **Alkarkh Health Directorate-Baghdad** · enrollment: 140 (actual)

## Conditions studied

- Covid19

## Interventions

- **DRUG:** Ivermectin and Doxycyline
- **DRUG:** Standard of care

## Key facts

- **NCT ID:** NCT04591600
- **Lead sponsor:** Alkarkh Health Directorate-Baghdad
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-01
- **Primary completion:** 2020-09-30
- **Final completion:** 2020-10-14
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2020-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04591600

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04591600, "Effectiveness of Ivermectin and Doxycycline on COVID-19 Patients". Retrieved via MORVS 2026-11-03 from https://api.morvs.ai/clinical/NCT04591600. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*